Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 760 participants.

Also called NCT03661411

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 760 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03661411
Other papers using this trial's data
  • Dual Antiplatelet Therapy Versus Alteplase for Mild Stroke with Admission NIHSS Score 0-3 Versus 4-5: A Secondary Analysis of the ARAMIS Randomized Trial CNS drugs, 2025-10 DOI, PubMed 40760234
  • Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke: The ARAMIS Randomized Clinical Trial JAMA, 2023-06-27 DOI, PubMed 37367978, PMC10300686 Not in the PMC Open Access subset.
  • Dual Antiplatelet Versus Alteplase for Early Neurologic Deterioration in Minor Stroke With Versus Without Large Vessel Occlusion: Prespecified Post Hoc Analysis of the ARAMIS Trial Stroke, 2024-11 DOI, PubMed 39387110
  • Onset to Treatment Time and Early Neurological Deterioration of Dual Antiplatelet Therapy Versus Alteplase in Minor Stroke Journal of the American Heart Association, 2025-11-04 DOI, PubMed 41128284, PMC12684577 In the PMC Open Access subset under CC BY-NC.
  • Systolic blood pressure and early neurological deterioration in minor stroke: A post hoc analysis of ARAMIS trial CNS neuroscience & therapeutics, 2024-07 DOI, PubMed 39014552, PMC11252017 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03661411. Randomized; no masking; primary purpose treatment. Start 2018-10-17 (actual); primary completion 2022-07-18 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke
Acronym
ARAMIS
Condition
Stroke
Intervention (Drug)
Aspirin
Intervention (Drug)
Clopidogrel 75mg
Intervention (Drug)
Alteplase
Lead sponsor
General Hospital of Shenyang Military Region (class: other)

Record details

Record id
cardio:ct-nct03661411
Content hash
094a152342f1e6e6847db22982abeb690811a1407a972ed2db2d3d8fa60392a2